Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
742.12
+3.40 (0.46%)
At close: Oct 7, 2026, 4:00 PM EDT
760.00
+17.88 (2.41%)
After-hours: Oct 7, 2026, 7:56 PM EDT
Regeneron Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains $772 → $780 | Buy | Maintains | $772 → $780 | +5.10% | Oct 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $779 | Hold | Reiterates | $779 | +4.97% | Oct 7, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $900 → $950 | Buy | Reiterates | $900 → $950 | +28.01% | Oct 6, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $761 | Hold | Maintains | $761 | +2.54% | Oct 2, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $972 | Buy | Maintains | $972 | +30.98% | Oct 2, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Oct 2, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $854 | Buy | Maintains | $854 | +15.08% | Oct 2, 2026 |
| Scotiabank | Scotiabank | Hold Maintains $770 | Hold | Maintains | $770 | +3.76% | Oct 2, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.